Buscar Company Acquires 70% Stake in Armorgenix
June 3, 2025
Buscar Company (OTC: CGLD) has acquired a 70% equity stake in Armorgenix Company via a strategic stock swap, making Armorgenix a key subsidiary. The deal expands Buscar's portfolio into pharmaceuticals—particularly antiviral and detoxification products such as DetoxShield—and includes plans for a Texas manufacturing facility and a Wyoming entity to manage IP and U.S. commercialization.
- Buyers
- Buscar Company (OTC: CGLD)
- Targets
- Armorgenix Company
- Industry
- Pharmaceuticals
- Location
- Wisconsin, United States
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.